Jones Financial Companies Lllp raised its position in Dolby Laboratories (NYSE:DLB - Free Report) by 241,160.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 429,443 shares of the electronics maker's stock after purchasing an additional 429,265 shares during the quarter. Jones Financial Companies Lllp owned about 0.45% of Dolby Laboratories worth $36,975,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in the company. Sepio Capital LP increased its stake in shares of Dolby Laboratories by 68.6% in the first quarter. Sepio Capital LP now owns 18,188 shares of the electronics maker's stock valued at $1,461,000 after purchasing an additional 7,403 shares during the period. Jacobs Levy Equity Management Inc. increased its stake in shares of Dolby Laboratories by 359.8% in the first quarter. Jacobs Levy Equity Management Inc. now owns 43,923 shares of the electronics maker's stock valued at $3,527,000 after purchasing an additional 34,370 shares during the period. AQR Capital Management LLC increased its stake in shares of Dolby Laboratories by 63.6% in the first quarter. AQR Capital Management LLC now owns 1,143,978 shares of the electronics maker's stock valued at $90,946,000 after purchasing an additional 444,718 shares during the period. Advisors Asset Management Inc. increased its stake in shares of Dolby Laboratories by 6.4% in the first quarter. Advisors Asset Management Inc. now owns 4,830 shares of the electronics maker's stock valued at $388,000 after purchasing an additional 291 shares during the period. Finally, EP Wealth Advisors LLC acquired a new stake in shares of Dolby Laboratories in the first quarter valued at approximately $379,000. Institutional investors and hedge funds own 58.56% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have commented on DLB. Rosenblatt Securities restated a "buy" rating and issued a $95.00 price target on shares of Dolby Laboratories in a research note on Friday, August 1st. Baird R W upgraded shares of Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Barrington Research reiterated an "outperform" rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Friday. Tigress Financial increased their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a report on Friday, August 15th. Finally, Robert W. Baird began coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They issued a "neutral" rating and a $74.00 price objective for the company. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $95.75.
Read Our Latest Analysis on Dolby Laboratories
Insider Buying and Selling
In related news, CEO Kevin J. Yeaman sold 39,875 shares of the firm's stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total value of $2,983,447.50. Following the completion of the transaction, the chief executive officer owned 114,725 shares of the company's stock, valued at approximately $8,583,724.50. This trade represents a 25.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares of the company's stock, valued at $5,276,990.20. This represents a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 99,366 shares of company stock valued at $7,352,963 in the last ninety days. Company insiders own 38.39% of the company's stock.
Dolby Laboratories Stock Down 0.9%
NYSE:DLB traded down $0.63 during trading hours on Friday, reaching $71.48. 337,864 shares of the company's stock were exchanged, compared to its average volume of 440,754. The company has a market capitalization of $6.85 billion, a P/E ratio of 26.18 and a beta of 0.93. Dolby Laboratories has a 12 month low of $68.24 and a 12 month high of $89.66. The business's 50-day simple moving average is $73.73 and its two-hundred day simple moving average is $75.49.
Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. During the same period last year, the firm posted $0.71 earnings per share. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, sell-side analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were paid a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. Dolby Laboratories's dividend payout ratio (DPR) is currently 48.35%.
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Recommended Stories

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report